Text Size

Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families

The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2008 by Imperial College London.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
British Heart Foundation
Information provided by:
Imperial College London
ClinicalTrials.gov Identifier:
NCT00230620
First received: September 29, 2005
Last updated: August 12, 2008
Last verified: August 2008
History of Changes
  Purpose

Hereditary haemorrhagic telangiectasia is a disease inherited as an autosomal dominant disease. Analysing DNA from affected and unaffected family members allows us to identify the location of disease genes by linkage analysis. Sequencing genes in the interval identified by linkage analysis allows us to identify which precise gene is mutated. Further functional studies can then determine why the mutations in that gene cause the disease.


Condition
Telangiectasia, Hereditary Hemorrhagic

Study Type: Observational
Official Title: Molecular Studies on Hereditary Haemorrhagic Telangiectasia Families With Pulmonary Arteriovenous Malformations

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Imperial College London:

Estimated Enrollment: 250
Study Start Date: December 1998
  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Member of family affected by HHT

Exclusion Criteria:

  • Unable or unwilling to provide informed consent for DNA sample
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00230620

Contacts
Contact: Claire L Shovlin 0208 383 1000 c.shovlin@imperial.ac.uk

Locations
United Kingdom
Imperial College Hammersmith Campus Recruiting
London, United Kingdom, W12 0NN
Contact: Claire L Shovlin     0208 383 1000     c.shovlin@imperial.ac.uk    
Principal Investigator: Claire L Shovlin            
Sponsors and Collaborators
Imperial College London
British Heart Foundation
Investigators
Principal Investigator: Claire L Shovlin Imperial College London
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00230620     History of Changes
Other Study ID Numbers: IC/CLS1
Study First Received: September 29, 2005
Last Updated: August 12, 2008
Health Authority: United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Arteriovenous Malformations
Telangiectasia, Hereditary Hemorrhagic
Telangiectasis
Vascular Malformations
Cardiovascular Abnormalities
Cardiovascular Diseases
 Vascular Diseases
Congenital Abnormalities
Hemostatic Disorders
Hemorrhagic Disorders
Hematologic Diseases

ClinicalTrials.gov processed this record on May 19, 2013